Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet M Kluger

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Oncology (Williston Park, N.Y.)|February 8, 2011
Ipilimumab: a promising immunotherapy for melanomaJaykumar R Thumar, Harriet M Kluger
Journal of Cellular Biochemistry|October 19, 2011
Immunotherapy for metastatic melanomaChristopher R Zito, Harriet M Kluger
Current Oncology Reports|February 25, 2022
Emerging Studies of Melanoma Brain MetastasisJasmine I Caulfield, Harriet M Kluger
Current Oncology Reports|June 23, 2012
Driver mutations in melanoma: lessons learned from bench-to-bedside studiesJanice M Mehnert, Harriet M Kluger
Frontiers in Oncology|March 26, 2016
Systemic Immunotherapy for the Treatment of Brain MetastasesJustine V Cohen, Harriet M Kluger
Cancer Journal (Sudbury, Mass.)|January 24, 2017
From the Guest Editors: Recent Advances and Evolving Challenges in Treating Unresectable MelanomaSarah A Weiss, Harriet M Kluger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Advances in Cancer Immunotherapy for Solid TumorsShira Gabizon-Peretz, Harriet M Kluger
Oncology (Williston Park, N.Y.)|September 4, 2014
Advances in the systemic treatment of metastatic melanomaMelinda Yushak, Harriet M Kluger, Mario Sznol
Pharmacogenomics and Personalized Medicine|December 11, 2012
Drug targets and predictive biomarkers in the management of metastatic melanomaJaykumar Thumar, Eva Giesen, Harriet M Kluger
Cancers|April 3, 2021
Agonistic CD40 Antibodies in Cancer TreatmentDijana Djureinovic, Meina Wang, Harriet M Kluger
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Oncology (Williston Park, N.Y.)|February 8, 2011
Ipilimumab: a promising immunotherapy for melanomaJaykumar R Thumar, Harriet M Kluger
Journal of Cellular Biochemistry|October 19, 2011
Immunotherapy for metastatic melanomaChristopher R Zito, Harriet M Kluger
Current Oncology Reports|February 25, 2022
Emerging Studies of Melanoma Brain MetastasisJasmine I Caulfield, Harriet M Kluger
Current Oncology Reports|June 23, 2012
Driver mutations in melanoma: lessons learned from bench-to-bedside studiesJanice M Mehnert, Harriet M Kluger
Frontiers in Oncology|March 26, 2016
Systemic Immunotherapy for the Treatment of Brain MetastasesJustine V Cohen, Harriet M Kluger
Cancer Journal (Sudbury, Mass.)|January 24, 2017
From the Guest Editors: Recent Advances and Evolving Challenges in Treating Unresectable MelanomaSarah A Weiss, Harriet M Kluger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2026
Advances in Cancer Immunotherapy for Solid TumorsShira Gabizon-Peretz, Harriet M Kluger
Oncology (Williston Park, N.Y.)|September 4, 2014
Advances in the systemic treatment of metastatic melanomaMelinda Yushak, Harriet M Kluger, Mario Sznol
Pharmacogenomics and Personalized Medicine|December 11, 2012
Drug targets and predictive biomarkers in the management of metastatic melanomaJaykumar Thumar, Eva Giesen, Harriet M Kluger
Cancers|April 3, 2021
Agonistic CD40 Antibodies in Cancer TreatmentDijana Djureinovic, Meina Wang, Harriet M Kluger
Pageof 20